Influence of protease inhibitor therapy on lipoprotein metabolism
- 25 December 1999
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 246 (6) , 567-575
- https://doi.org/10.1046/j.1365-2796.1999.00615.x
Abstract
Berthold HK, Parhofer KG, Ritter MM, Addo M, Wasmuth JC, Schliefer K, Spengler U, Rockstroh JK (University of Bonn and University of Munich, Germany). Influence of protease inhibitor therap...Keywords
This publication has 23 references indexed in Scilit:
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- British HIV Association guidelines for antiretroviral treatment of HIV seropositive individualsThe Lancet, 1997
- HIV-1 protease inhibitors. A review for cliniciansJAMA, 1997
- A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 ProteaseNew England Journal of Medicine, 1995
- Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agentsAntimicrobial Agents and Chemotherapy, 1993
- Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infectionThe American Journal of Medicine, 1993
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976